CLINICAL_TRIALS
trial_result
· 2013-11-20
Clinical Trial Update: Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma [Phase 2]
Summary
A Phase 2 trial assessing tolerability and pharmacokinetics of submicron budesonide in children aged 4 to 11 with mild-to-moderate stable asthma; the study has …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-11-20